Should We Use Outpatient Dobutamine or Milrinone?
نویسندگان
چکیده
منابع مشابه
Should we stay or should we go?
With the potential benefit of positive movement in the housing market and now having two properties this may place you in a good position to increase your retirement nest egg if you choose to sell your family home when you downsize. Depending on your situation you may even be able to keep the family home as an investment. One of the biggest decisions for many retirees is whether to stay in the ...
متن کاملDifferent Stroke Scales; Which Scale or Scales Should Be Use?
Background: There has been considerable development in the clinometric of stroke. But, researcher is concerned that some scales are too generic, inherently and the insight may not be provided. The current study was conducted to determine which scale or scales should be used in stroke survivors. Methods: We selected 67 studies which published between January 2010 and December 2018 from Up to d...
متن کاملPrognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
BACKGROUND There are no published clinical trials comparing dobutamine with milrinone in outpatients with stage D heart failure on continuous inotropes. METHODS AND RESULTS In a retrospective analysis of 112 inotrope-dependent patients with stage D heart failure who were not transplant candidates at enrollment, we investigated the relationship between choice of dobutamine or milrinone and mor...
متن کاملRehabilitation Services: Why should we use Tele-rehabilitation in IRAN? (Necessity and Application)
People living in rural areas far from health care centers are more likely to require health care services due to their long distances services and poverty(1). Tele-rehabilitation is considered as one of the rapidly emerging and growing areas of telemedicine and a precious model for providing clinical services like assessment, treatment and follows up as well as reducing the length of time for h...
متن کاملIgA deficiency: what we should-or should not-be doing.
Although IgA deficiency (IgAD) is currently recognised as the most frequent immunodeficiency in humans, individuals with IgAD are largely considered to be healthy and when discovered are usually not investigated further or followed up. The rare occasion when IgAD is a cause for concern is when these individuals require blood or blood products, in which case current practice advises that product...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation: Heart Failure
سال: 2009
ISSN: 1941-3289,1941-3297
DOI: 10.1161/circheartfailure.109.849265